Results 271 to 280 of about 480,155 (368)

Cost of Illness Study on Oral Cancer in Australia

open access: yesOral Diseases, EarlyView.
ABSTRACT Objectives The aim of this study is to estimate the economic burden of oral cancer in Australia from the societal perspective. Methods The population consisted of the prevalence of lip and oral cavity cancer, and other lip, oral cavity, and pharynx cancers for ages 40 years and older.
M. A. B. Gama   +4 more
wiley   +1 more source

Oral Granular Cell Tumour on the Mandibular Gingiva in an Adult: A Rare Case Report. [PDF]

open access: yesCase Rep Dent
Iijima Y   +6 more
europepmc   +1 more source

The Complexities and Challenges of Managing Genetic Causes of Hyperphosphataemia, a Case Report

open access: yes
Journal of Paediatrics and Child Health, EarlyView.
Farrah Rodrigues   +3 more
wiley   +1 more source

Temporomandibular Disorders in Brain Injury Patients and Diagnostic Accuracy of the Assessment Tools

open access: yesOral Diseases, EarlyView.
ABSTRACT Objectives To evaluate the presence, severity and progression of temporomandibular disorders (TMD) in acquired brain injury (ABI) population and determine the diagnostic accuracy of 3Q/TMD and Fonseca Anamnestic Index (FAI) against the gold standard, Diagnostic Criteria for TMD (DC/TMD).
Mohit Kothari   +6 more
wiley   +1 more source

Deciphering Disulfidptosis‐Linked lncRNA Patterns as Potential HNSCC Biomarkers

open access: yesOral Diseases, EarlyView.
ABSTRACT Background Our investigation sought to uncover the intrinsic features of Head and Neck Squamous Cell Carcinoma (HNSCC), particularly the role of long non‐coding RNAs implicated in disulfidptosis (DRLs). Materials and Methods We carried out lncRNA‐mRNA RNA‐Seq studies on HNSCC cells and harnessed the data from The Cancer Genome Atlas (TCGA ...
Qi Chen   +3 more
wiley   +1 more source

Non‐Anticoagulant Heparin: An In Vitro Investigation of a Novel Therapeutic Approach for Oral Cancer

open access: yesOral Diseases, EarlyView.
ABSTRACT Background Oral squamous cell carcinoma (OSCC) represents a significant global oral health concern. Non‐anticoagulant heparin (NH) emerges as a promising solution considering the enhanced survival observed with anticoagulants in cancer treatment. Methods We used the MTS assay (0/24/48/72 h), scratch assay (MuviCyte, 0–18 h), invasion Matrigel (
S. A. Hamza   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy